A comprehensive view of eli lilly & co.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Eli Lilly and Company Seeks Patent for Extended Time Action Acylated Insulin Compounds
Published: March 25, 2023 by Pharmaceutical Patent News
Australia: Eli Lilly and Co. Receives Patent for 'An Aurora A kinase inhibitor for use in the treatment of neuroblastoma'
Published: March 24, 2023 by Australian Government
Australia: Eli Lilly and Co. Receives Patent for 'Methods of determining protein or peptide concentration and uses thereof'
Published: March 24, 2023 by Australian Government
Roche partners with Eli Lilly to support development of Roche’s Elecsys Amyloid Plasma Panel blood test to facilitate earlier diagnosis of Alzheimer’s disease; about 75% of people showing symptoms of Alzheimer’s globally do not have a diagnosis
Published: March 23, 2023 by Marketline - Deals
Supporters of People for the Ethical Treatment of Animals confront Eli Lilly CEO during speech at Adobe Summit in Venice about animal test used by Lilly in depression studies; ‘forced swimming’ test has been banned by other pharma companies
Published: March 22, 2023 by States News Service

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count